Synaptic plasticity in the rat striatum following chronic haloperidol treatment
Administration of the dopamine (DA) antagonist haloperidol leads to the development of behavioral hypersensitivity as well as enhanced neuronal growth when striatal extracts from these animals are incubated with mesencephalic cultures. For determining if alterations in neuronal growth also occur in...
Gespeichert in:
Veröffentlicht in: | Clinical neuropharmacology 1992-12, Vol.15 (6), p.488-500 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 500 |
---|---|
container_issue | 6 |
container_start_page | 488 |
container_title | Clinical neuropharmacology |
container_volume | 15 |
creator | KERNS, J. M SIERENS, D. K LI CHIUNG KAO KLAWANS, H. L CARVEY, P. M |
description | Administration of the dopamine (DA) antagonist haloperidol leads to the development of behavioral hypersensitivity as well as enhanced neuronal growth when striatal extracts from these animals are incubated with mesencephalic cultures. For determining if alterations in neuronal growth also occur in vivo, the ultrastructure of the neuropil in the dorsolateral quadrant of the striatum from rats treated (24 days) with haloperidol (1.25 mg/kg) was examined by electron microscopy. Haloperidol-treated rats developed statistically significant behavioral hypersensitivity relative to vehicle-treated controls (p < 0.01). Evaluation of the neuropil revealed that haloperidol treatment enhanced, relative to vehicle-treated controls, the overall number of synaptic boutons by 9% (p < 0.01). The number of perforated synaptic profiles as well as the number of double synapses was increased by 20 and 50%, respectively, although this increase was not statistically significant. The number of myelinated axons remained unchanged, while the number of dendritic spines was increased by 21% (p < 0.05). These data suggest that chronic haloperidol treatment enhanced the growth and possible sprouting of presynaptic neurons and also induced postsynaptic plastic changes. These ultrastructural changes may contribute in part to hypersensitivity behaviors. |
doi_str_mv | 10.1097/00002826-199212000-00006 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73434210</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73434210</sourcerecordid><originalsourceid>FETCH-LOGICAL-c339t-a64b1c64ea3578f0588b087b851fb90e81f9232703b2f682cf4fd0be1429654d3</originalsourceid><addsrcrecordid>eNpFUMtKAzEUDaLUWv0EIQtxN5rXZJKlFF9Q6EIFd0MmTWwk8zDJIP17U1vr3RzuedwLBwCI0Q1GsrpFeYggvMBSEkzyVmwpfgSmuKRVgTl5PwZTRDkpSs7ZKTiL8TM7hGRyAiaY0lLQagqWL5tODclpOHgVM7q0ga6DaW1gUAnGFJxKYwtt733_7boPqNeh73JgrXw_mOBWvYcpGJVa06VzcGKVj-ZijzPw9nD_On8qFsvH5_ndotCUylQozhqsOTOKlpWwqBSiQaJqRIltI5ER2EpCSYVoQywXRFtmV6gxmBHJS7aiM3C9uzuE_ms0MdWti9p4rzrTj7GuKKOMYJSNYmfUoY8xGFsPwbUqbGqM6m2X9V-X9aHLX4rn6OX-x9i0ZvUf3JWX9au9rqJW3gbVaRcPNsaopBzRH7oTfEE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73434210</pqid></control><display><type>article</type><title>Synaptic plasticity in the rat striatum following chronic haloperidol treatment</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>KERNS, J. M ; SIERENS, D. K ; LI CHIUNG KAO ; KLAWANS, H. L ; CARVEY, P. M</creator><creatorcontrib>KERNS, J. M ; SIERENS, D. K ; LI CHIUNG KAO ; KLAWANS, H. L ; CARVEY, P. M</creatorcontrib><description>Administration of the dopamine (DA) antagonist haloperidol leads to the development of behavioral hypersensitivity as well as enhanced neuronal growth when striatal extracts from these animals are incubated with mesencephalic cultures. For determining if alterations in neuronal growth also occur in vivo, the ultrastructure of the neuropil in the dorsolateral quadrant of the striatum from rats treated (24 days) with haloperidol (1.25 mg/kg) was examined by electron microscopy. Haloperidol-treated rats developed statistically significant behavioral hypersensitivity relative to vehicle-treated controls (p < 0.01). Evaluation of the neuropil revealed that haloperidol treatment enhanced, relative to vehicle-treated controls, the overall number of synaptic boutons by 9% (p < 0.01). The number of perforated synaptic profiles as well as the number of double synapses was increased by 20 and 50%, respectively, although this increase was not statistically significant. The number of myelinated axons remained unchanged, while the number of dendritic spines was increased by 21% (p < 0.05). These data suggest that chronic haloperidol treatment enhanced the growth and possible sprouting of presynaptic neurons and also induced postsynaptic plastic changes. These ultrastructural changes may contribute in part to hypersensitivity behaviors.</description><identifier>ISSN: 0362-5664</identifier><identifier>EISSN: 1537-162X</identifier><identifier>DOI: 10.1097/00002826-199212000-00006</identifier><identifier>PMID: 1335837</identifier><identifier>CODEN: CLNEDB</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott</publisher><subject>Animals ; Axons - drug effects ; Axons - ultrastructure ; Biological and medical sciences ; Corpus Striatum - drug effects ; Corpus Striatum - ultrastructure ; Dendrites - drug effects ; Dendrites - ultrastructure ; Deoxyglucose - pharmacology ; Dopamine - metabolism ; Haloperidol - pharmacology ; Male ; Medical sciences ; Neuronal Plasticity - drug effects ; Neuropharmacology ; Pharmacology. Drug treatments ; Psycholeptics: tranquillizer, neuroleptic ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Rats ; Rats, Sprague-Dawley ; Synapses - drug effects ; Synapses - ultrastructure ; Synaptic Transmission - drug effects</subject><ispartof>Clinical neuropharmacology, 1992-12, Vol.15 (6), p.488-500</ispartof><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c339t-a64b1c64ea3578f0588b087b851fb90e81f9232703b2f682cf4fd0be1429654d3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4439360$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1335837$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KERNS, J. M</creatorcontrib><creatorcontrib>SIERENS, D. K</creatorcontrib><creatorcontrib>LI CHIUNG KAO</creatorcontrib><creatorcontrib>KLAWANS, H. L</creatorcontrib><creatorcontrib>CARVEY, P. M</creatorcontrib><title>Synaptic plasticity in the rat striatum following chronic haloperidol treatment</title><title>Clinical neuropharmacology</title><addtitle>Clin Neuropharmacol</addtitle><description>Administration of the dopamine (DA) antagonist haloperidol leads to the development of behavioral hypersensitivity as well as enhanced neuronal growth when striatal extracts from these animals are incubated with mesencephalic cultures. For determining if alterations in neuronal growth also occur in vivo, the ultrastructure of the neuropil in the dorsolateral quadrant of the striatum from rats treated (24 days) with haloperidol (1.25 mg/kg) was examined by electron microscopy. Haloperidol-treated rats developed statistically significant behavioral hypersensitivity relative to vehicle-treated controls (p < 0.01). Evaluation of the neuropil revealed that haloperidol treatment enhanced, relative to vehicle-treated controls, the overall number of synaptic boutons by 9% (p < 0.01). The number of perforated synaptic profiles as well as the number of double synapses was increased by 20 and 50%, respectively, although this increase was not statistically significant. The number of myelinated axons remained unchanged, while the number of dendritic spines was increased by 21% (p < 0.05). These data suggest that chronic haloperidol treatment enhanced the growth and possible sprouting of presynaptic neurons and also induced postsynaptic plastic changes. These ultrastructural changes may contribute in part to hypersensitivity behaviors.</description><subject>Animals</subject><subject>Axons - drug effects</subject><subject>Axons - ultrastructure</subject><subject>Biological and medical sciences</subject><subject>Corpus Striatum - drug effects</subject><subject>Corpus Striatum - ultrastructure</subject><subject>Dendrites - drug effects</subject><subject>Dendrites - ultrastructure</subject><subject>Deoxyglucose - pharmacology</subject><subject>Dopamine - metabolism</subject><subject>Haloperidol - pharmacology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neuronal Plasticity - drug effects</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Psycholeptics: tranquillizer, neuroleptic</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Synapses - drug effects</subject><subject>Synapses - ultrastructure</subject><subject>Synaptic Transmission - drug effects</subject><issn>0362-5664</issn><issn>1537-162X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFUMtKAzEUDaLUWv0EIQtxN5rXZJKlFF9Q6EIFd0MmTWwk8zDJIP17U1vr3RzuedwLBwCI0Q1GsrpFeYggvMBSEkzyVmwpfgSmuKRVgTl5PwZTRDkpSs7ZKTiL8TM7hGRyAiaY0lLQagqWL5tODclpOHgVM7q0ga6DaW1gUAnGFJxKYwtt733_7boPqNeh73JgrXw_mOBWvYcpGJVa06VzcGKVj-ZijzPw9nD_On8qFsvH5_ndotCUylQozhqsOTOKlpWwqBSiQaJqRIltI5ER2EpCSYVoQywXRFtmV6gxmBHJS7aiM3C9uzuE_ms0MdWti9p4rzrTj7GuKKOMYJSNYmfUoY8xGFsPwbUqbGqM6m2X9V-X9aHLX4rn6OX-x9i0ZvUf3JWX9au9rqJW3gbVaRcPNsaopBzRH7oTfEE</recordid><startdate>19921201</startdate><enddate>19921201</enddate><creator>KERNS, J. M</creator><creator>SIERENS, D. K</creator><creator>LI CHIUNG KAO</creator><creator>KLAWANS, H. L</creator><creator>CARVEY, P. M</creator><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19921201</creationdate><title>Synaptic plasticity in the rat striatum following chronic haloperidol treatment</title><author>KERNS, J. M ; SIERENS, D. K ; LI CHIUNG KAO ; KLAWANS, H. L ; CARVEY, P. M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c339t-a64b1c64ea3578f0588b087b851fb90e81f9232703b2f682cf4fd0be1429654d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Animals</topic><topic>Axons - drug effects</topic><topic>Axons - ultrastructure</topic><topic>Biological and medical sciences</topic><topic>Corpus Striatum - drug effects</topic><topic>Corpus Striatum - ultrastructure</topic><topic>Dendrites - drug effects</topic><topic>Dendrites - ultrastructure</topic><topic>Deoxyglucose - pharmacology</topic><topic>Dopamine - metabolism</topic><topic>Haloperidol - pharmacology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neuronal Plasticity - drug effects</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Psycholeptics: tranquillizer, neuroleptic</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Synapses - drug effects</topic><topic>Synapses - ultrastructure</topic><topic>Synaptic Transmission - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KERNS, J. M</creatorcontrib><creatorcontrib>SIERENS, D. K</creatorcontrib><creatorcontrib>LI CHIUNG KAO</creatorcontrib><creatorcontrib>KLAWANS, H. L</creatorcontrib><creatorcontrib>CARVEY, P. M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical neuropharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KERNS, J. M</au><au>SIERENS, D. K</au><au>LI CHIUNG KAO</au><au>KLAWANS, H. L</au><au>CARVEY, P. M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synaptic plasticity in the rat striatum following chronic haloperidol treatment</atitle><jtitle>Clinical neuropharmacology</jtitle><addtitle>Clin Neuropharmacol</addtitle><date>1992-12-01</date><risdate>1992</risdate><volume>15</volume><issue>6</issue><spage>488</spage><epage>500</epage><pages>488-500</pages><issn>0362-5664</issn><eissn>1537-162X</eissn><coden>CLNEDB</coden><abstract>Administration of the dopamine (DA) antagonist haloperidol leads to the development of behavioral hypersensitivity as well as enhanced neuronal growth when striatal extracts from these animals are incubated with mesencephalic cultures. For determining if alterations in neuronal growth also occur in vivo, the ultrastructure of the neuropil in the dorsolateral quadrant of the striatum from rats treated (24 days) with haloperidol (1.25 mg/kg) was examined by electron microscopy. Haloperidol-treated rats developed statistically significant behavioral hypersensitivity relative to vehicle-treated controls (p < 0.01). Evaluation of the neuropil revealed that haloperidol treatment enhanced, relative to vehicle-treated controls, the overall number of synaptic boutons by 9% (p < 0.01). The number of perforated synaptic profiles as well as the number of double synapses was increased by 20 and 50%, respectively, although this increase was not statistically significant. The number of myelinated axons remained unchanged, while the number of dendritic spines was increased by 21% (p < 0.05). These data suggest that chronic haloperidol treatment enhanced the growth and possible sprouting of presynaptic neurons and also induced postsynaptic plastic changes. These ultrastructural changes may contribute in part to hypersensitivity behaviors.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott</pub><pmid>1335837</pmid><doi>10.1097/00002826-199212000-00006</doi><tpages>13</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0362-5664 |
ispartof | Clinical neuropharmacology, 1992-12, Vol.15 (6), p.488-500 |
issn | 0362-5664 1537-162X |
language | eng |
recordid | cdi_proquest_miscellaneous_73434210 |
source | MEDLINE; Journals@Ovid Complete |
subjects | Animals Axons - drug effects Axons - ultrastructure Biological and medical sciences Corpus Striatum - drug effects Corpus Striatum - ultrastructure Dendrites - drug effects Dendrites - ultrastructure Deoxyglucose - pharmacology Dopamine - metabolism Haloperidol - pharmacology Male Medical sciences Neuronal Plasticity - drug effects Neuropharmacology Pharmacology. Drug treatments Psycholeptics: tranquillizer, neuroleptic Psychology. Psychoanalysis. Psychiatry Psychopharmacology Rats Rats, Sprague-Dawley Synapses - drug effects Synapses - ultrastructure Synaptic Transmission - drug effects |
title | Synaptic plasticity in the rat striatum following chronic haloperidol treatment |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T05%3A11%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synaptic%20plasticity%20in%20the%20rat%20striatum%20following%20chronic%20haloperidol%20treatment&rft.jtitle=Clinical%20neuropharmacology&rft.au=KERNS,%20J.%20M&rft.date=1992-12-01&rft.volume=15&rft.issue=6&rft.spage=488&rft.epage=500&rft.pages=488-500&rft.issn=0362-5664&rft.eissn=1537-162X&rft.coden=CLNEDB&rft_id=info:doi/10.1097/00002826-199212000-00006&rft_dat=%3Cproquest_cross%3E73434210%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73434210&rft_id=info:pmid/1335837&rfr_iscdi=true |